{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"irvan","columns":[{"gene":"","key":"population-ae2b9f008c746e3ed84b","label":"IRVAN syndrome","mondoId":"MONDO:0016205","onsetQualifier":null,"originColumnKey":"MONDO:0016205/ORPHA:209943","originalViews":[{"key":"MONDO:0016205/ORPHA:209943","label":"IRVAN syndrome","scopeLabel":"ORPHA:209943","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["0526edbe3b1f5e4c2c2f2004d94b66aa6da17d096fdd050af071a2dd4b508e53","0b9de1c84033f95968e0cdc9e110a8962934b0898ff56729e810600eb64d41bd","2338c7bc3801a9365d60ea02c02a0ce7de188823b8f10cc95c8617b168365d69","30514bb3786c692828ef25d0ce8e8f3a4bc713280156ba21d59581aa19a2fee5","316643854ae088033da59bedc47e1ea202942e2bcfe3da6561031b02bf387ec1","755849016bff1b3ce407796926e189419de49580e17560909b42b43ca650cacf","956cd004ddaa8c84bf4f54dd3f032273bcda61a395bb1af902af88a77ae296b5","b3f743ac8986f8eb8e56e666d22b62e00e3e63f273b760783a0356914ef7a9df","da37a10184522de7db626d6d72f37b2eb835441ac226aa93092a020c4a78f964","e50cc1ec9815941774a34f3aac63ff5d26eb5e90e93005c19ff1b082d3e639d6","fabe742cee338ce618f56a51bfbe959e00f7575027086d7524e338bc07ac43a1"],"recordQualifiers":{},"scopeLabel":"ORPHA:209943","sourceIds":["ORPHA:209943"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-ae2b9f008c746e3ed84b"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0000622","HP:0000501","HP:0040049","HP:0007906","HP:0000648","HP:0000613","HP:0007663"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":11,"sourceGroups":{"orphanet":11}},"features":[{"hpoId":"HP:0000622","label":"Blurred vision","primary":true},{"hpoId":"HP:0000501","label":"Glaucoma","primary":true},{"hpoId":"HP:0040049","label":"Macular edema","primary":true},{"hpoId":"HP:0007906","label":"Ocular hypertension","primary":true},{"hpoId":"HP:0000648","label":"Optic atrophy","primary":true},{"hpoId":"HP:0000613","label":"Photophobia","primary":true},{"hpoId":"HP:0007663","label":"Reduced visual acuity","primary":true},{"hpoId":"HP:0000541","label":"Retinal detachment","primary":false},{"hpoId":"HP:0001147","label":"Retinal exudate","primary":false},{"hpoId":"HP:0007917","label":"Tractional retinal detachment","primary":false},{"hpoId":"HP:0100832","label":"Vitreous floaters","primary":false}],"ledeHtml":"A rare retinal vasculopathy disease characterized by idiopathic retinal vasculitis (IRV), aneurysmal dilations (A) at arteriolar bifurcations, and neuroretinitis (N), which if untreated progresses to peripheral capillary non-perfusion, retinal neovascularization, and macular exudation, leading to severe, bilateral vision loss.","mondoId":"MONDO:0016205","node":{"canonicalSlug":"irvan","comparisons":[{"documentSha256":"0af857ab02bcf9106b3d21dadc0226eb11298f951712d592c5b4aedef8fa0fb9","key":"legacy-irvan","kind":"legacy","label":"IRVAN syndrome","memberIds":["MONDO:0016205"],"mondoId":"MONDO:0016205","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/irvan.0af857ab02bcf9106b3d21dadc0226eb11298f951712d592c5b4aedef8fa0fb9.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"IRVAN syndrome","originalSourceId":"ORPHA:209943","paragraphs":["A rare retinal vasculopathy disease characterized by idiopathic retinal vasculitis (IRV), aneurysmal dilations (A) at arteriolar bifurcations, and neuroretinitis (N), which if untreated progresses to peripheral capillary non-perfusion, retinal neovascularization, and macular exudation, leading to severe, bilateral vision loss."],"rawAttribution":"GARD:0012868","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-21T17:00:11Z","upstream":"GARD:0012868","url":"https://rarediseases.info.nih.gov/diseases/12868"},"ownColumnKeys":["population-ae2b9f008c746e3ed84b"],"publication":"published","relationships":[{"kind":"parent","label":"eye disorder","mondoId":"MONDO:0005328","slug":null}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"range","key":"0526edbe3b1f5e4c2c2f2004d94b66aa6da17d096fdd050af071a2dd4b508e53","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:209943","disease_name":"IRVAN syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0040049","is_excluded":false,"label":"Macular edema","onset_id":null,"reference":"ORPHA:209943","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"0b9de1c84033f95968e0cdc9e110a8962934b0898ff56729e810600eb64d41bd","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:209943","disease_name":"IRVAN syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000622","is_excluded":false,"label":"Blurred vision","onset_id":null,"reference":"ORPHA:209943","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2338c7bc3801a9365d60ea02c02a0ce7de188823b8f10cc95c8617b168365d69","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:209943","disease_name":"IRVAN syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000648","is_excluded":false,"label":"Optic atrophy","onset_id":null,"reference":"ORPHA:209943","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"30514bb3786c692828ef25d0ce8e8f3a4bc713280156ba21d59581aa19a2fee5","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:209943","disease_name":"IRVAN syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001147","is_excluded":false,"label":"Retinal exudate","onset_id":null,"reference":"ORPHA:209943","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"316643854ae088033da59bedc47e1ea202942e2bcfe3da6561031b02bf387ec1","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:209943","disease_name":"IRVAN syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000541","is_excluded":false,"label":"Retinal detachment","onset_id":null,"reference":"ORPHA:209943","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"755849016bff1b3ce407796926e189419de49580e17560909b42b43ca650cacf","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:209943","disease_name":"IRVAN syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000501","is_excluded":false,"label":"Glaucoma","onset_id":null,"reference":"ORPHA:209943","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"956cd004ddaa8c84bf4f54dd3f032273bcda61a395bb1af902af88a77ae296b5","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:209943","disease_name":"IRVAN syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0100832","is_excluded":false,"label":"Vitreous floaters","onset_id":null,"reference":"ORPHA:209943","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"b3f743ac8986f8eb8e56e666d22b62e00e3e63f273b760783a0356914ef7a9df","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:209943","disease_name":"IRVAN syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000613","is_excluded":false,"label":"Photophobia","onset_id":null,"reference":"ORPHA:209943","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"da37a10184522de7db626d6d72f37b2eb835441ac226aa93092a020c4a78f964","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:209943","disease_name":"IRVAN syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0007917","is_excluded":false,"label":"Tractional retinal detachment","onset_id":null,"reference":"ORPHA:209943","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e50cc1ec9815941774a34f3aac63ff5d26eb5e90e93005c19ff1b082d3e639d6","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:209943","disease_name":"IRVAN syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0007663","is_excluded":false,"label":"Reduced visual acuity","onset_id":null,"reference":"ORPHA:209943","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"fabe742cee338ce618f56a51bfbe959e00f7575027086d7524e338bc07ac43a1","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:209943","disease_name":"IRVAN syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0007906","is_excluded":false,"label":"Ocular hypertension","onset_id":null,"reference":"ORPHA:209943","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/12868\" rel=\"noreferrer\">GARD</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>GARD:0012868</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A rare retinal vasculopathy disease characterized by idiopathic retinal vasculitis (IRV), aneurysmal dilations (A) at arteriolar bifurcations, and neuroretinitis (N), which if untreated progresses to peripheral capillary non-perfusion, retinal neovascularization, and macular exudation, leading to severe, bilateral vision loss.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/12868\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"irvan","sourceDocuments":[{"name":"GARD: IRVAN syndrome","reviewed":null,"source_release":"2026-10-21T17:00:11Z","url":"https://rarediseases.info.nih.gov/diseases/12868"}],"sourceNote":"","synonyms":["idiopathic retinal vasculitis-aneurysms-neuroretinitis syndrome","idiopathic retinal-aneurysms-neuroretinitis syndrome"],"takeawayHtml":"","title":"IRVAN syndrome"},"schemaVersion":1}
